- Home
- MSGE vs DNLI Comparison
MSGE vs DNLI Comparison
Compare MSGE & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSGE
- DNLI
- Stock Information
- Founded
- MSGE 2020
- DNLI 2013
- Country
- MSGE United States
- DNLI United States
- Employees
- MSGE N/A
- DNLI N/A
- Industry
- MSGE Services-Misc. Amusement & Recreation
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MSGE Consumer Discretionary
- DNLI Health Care
- Exchange
- MSGE Nasdaq
- DNLI Nasdaq
- Market Cap
- MSGE 1.9B
- DNLI 2.1B
- IPO Year
- MSGE N/A
- DNLI 2017
- Fundamental
- Price
- MSGE $48.48
- DNLI $15.87
- Analyst Decision
- MSGE Buy
- DNLI Strong Buy
- Analyst Count
- MSGE 6
- DNLI 13
- Target Price
- MSGE $51.50
- DNLI $32.64
- AVG Volume (30 Days)
- MSGE 324.9K
- DNLI 1.5M
- Earning Date
- MSGE 11-06-2025
- DNLI 11-06-2025
- Dividend Yield
- MSGE N/A
- DNLI N/A
- EPS Growth
- MSGE N/A
- DNLI N/A
- EPS
- MSGE 0.72
- DNLI N/A
- Revenue
- MSGE $962,282,000.00
- DNLI N/A
- Revenue This Year
- MSGE $8.62
- DNLI N/A
- Revenue Next Year
- MSGE $5.08
- DNLI $94,232.03
- P/E Ratio
- MSGE $68.44
- DNLI N/A
- Revenue Growth
- MSGE 0.68
- DNLI N/A
- 52 Week Low
- MSGE $28.29
- DNLI $10.57
- 52 Week High
- MSGE $49.33
- DNLI $33.33
- Technical
- Relative Strength Index (RSI)
- MSGE 71.71
- DNLI 50.98
- Support Level
- MSGE $43.33
- DNLI $13.75
- Resistance Level
- MSGE $47.20
- DNLI $17.02
- Average True Range (ATR)
- MSGE 1.52
- DNLI 0.86
- MACD
- MSGE 0.29
- DNLI -0.19
- Stochastic Oscillator
- MSGE 99.47
- DNLI 54.05
About MSGE Madison Square Garden Entertainment Corp.
Madison Square Garden Entertainment Corp provides live entertainment, delivering unforgettable experiences while forging deep connections with diverse and passionate audiences. The company's portfolio includes a collection of world-renowned venues - New York's Madison Square Garden, The Theater at Madison Square Garden, Radio City Music Hall, and Beacon Theatre; and The Chicago Theatre - that showcase a broad array of sporting events, concerts, family shows, and special events for millions of guests annually. In addition, the company features the original production, the Christmas Spectacular Starring the Radio City Rockettes, which has been a holiday tradition for 89 years.
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.